Alliancebernstein L.P. Adagio Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.08 - $4.05 $30,184 - $39,690	9,800 Added 32.56%	39,900 $132,000
Q3 2022 Nov 15, 2022	BUY	$2.97 - $4.83 $16,038 - $26,082	5,400 Added 21.86%	30,100 $94,000
Q2 2022 Aug 15, 2022	BUY	$2.54 - $4.52 $28,956 - $51,527	11,400 Added 85.71%	24,700 $81,000
Q1 2022 May 13, 2022	SELL	$3.81 - $10.77 $31,242 - $88,314	-8,200 Reduced 38.14%	13,300 $61,000
Q3 2021 Nov 10, 2021	BUY	$20.88 - $56.08 $448,920 - $1.21 Million	21,500 New	21,500 $908,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.